FDA recall D-1190-2018
Baxter Healthcare Corporation · Class II · drug
Product
0.9% Sodium Chloride Injection USP 50 mL Viaflex container Baxter Healthcare Corporation Deerfield, IL 60015 -- NDC 0338-0049-31
Reason for recall
cGMP Deviation
Distribution
Nationwide.
Key facts
- Status
- Terminated
- Initiation date
- 2018-09-06
- Report date
- 2018-09-26
- Termination date
- 2020-10-01
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Deerfield, IL, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1190-2018